Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
October 1, 2004Current Pharmaceutical Design

Lipoproteins and Diabetic Microvascular Complications

View Full Paper
Ask AI
Bookmark
Share

Population

Patients with Type 1 and Type 2 diabetes mellitus

Design

Review

Authors

AJAlicia J. JenkinsKRKevin RowleyTLTimothy J. Lyons

Discussion

Loading...

Member takes

Overview

Hypothesis-generating for lipoprotein management in diabetic microvascular complications; randomized trials needed before practice change.

Structured PICO

P
Population
Patients with Type 1 and Type 2 diabetes mellitus

Optimal lipoprotein management as part of comprehensive diabetes care may help reduce the risk of microvascular complications and accelerated atherosclerosis.

Cite This Study

Jenkins et al. (2004) studied this question.

synapsesocial.com/papers/6a791a5170e13102dc6743ffhttps://doi.org/10.2174/1381612043383188
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Haemodynamics in microvascular complications in type 1 diabetes2002 · 41 citations
  2. 2Diabetes and atherosclerosis: An epidemiologic view1987 · 921 citations
  3. 3Triglyceride-Rich Lipoprotein Metabolism and Cardiovascular Risk in Diabetes: Bedside to Bench to Bedside2026 · 2 citations
  4. 4Modification of lipoprotein metabolism and function driving atherogenesis in diabetes2024 · 71 citations
  5. 5The Role of High-Density Lipoproteins in Diabetes and Its Vascular Complications2018 · 84 citations